NCT07453342 2026-03-06
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
Peking Union Medical College Hospital
Recruiting
Clinical Trials
15 trialsNCT07434518 2026-02-25
A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting
NCT04913311 2026-02-19
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Recruiting
NCT07389876 2026-02-05
G/GEJ
Fudan University
Recruiting
NCT07249060 2025-12-03
INTER-AUTENTIC
Hospital Universitario Araba
Recruiting
NCT07100405 2025-08-17
TASK-01-RW
Fudan University
Recruiting
NCT05486650 2025-07-14
An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
Xinqiao Hospital of Chongqing
Recruiting
NCT04977791 2025-05-22
Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer
Shanghai Chest Hospital
Recruiting
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT06869239 2025-03-11
Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy
Peking University Cancer Hospital & Institute
Recruiting
NCT06730503 2024-12-12
Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
Shanghai Chest Hospital
Recruiting
NCT06693440 2024-11-18
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Henan Cancer Hospital
Recruiting
NCT06505486 2024-07-17
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
NCT04807114 2024-07-01
A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC
Universitaire Ziekenhuizen KU Leuven
Recruiting
NCT05037825 2022-04-27
PARADIGM
VastBiome
Recruiting